Takeda moves for judgment in US reverse payment case over Amitiza (corrects*)
MLex Summary: Takeda Pharmaceuticals moved for a judgment against plaintiffs' US antitrust claims over an alleged reverse payment regarding the drug Amitiza*. It said that the relevant settlement provides that Par Pharmaceuticals,...To view the full article, register now.
Already a subscriber? Click here to view full article